Chapter 8 - Labelling guidance - Great Britain

AI Summary

The UK Medicines and Healthcare products Regulatory Agency (MHRA) issued this guidance to clarify labelling requirements for e-liquids sold in Great Britain, governed by the Tobacco and Related Products Regulations 2016 (TRPR). As a general regulatory document, it applies to all manufacturers and importers rather than a specific company or inspection date. The guidance addresses common issues regarding the placement and visibility of health warnings, which must occupy 30% of the packaging's primary surfaces. It also mandates a comprehensive list of ingredients, nicotine concentration levels, and batch numbers for traceability. Key violations discussed include the use of promotional language or health claims, such as suggesting e-liquids are safer than tobacco, which are strictly prohibited. Required actions for businesses include ensuring all packaging is child-resistant and tamper-evident, providing clear instructions for use, and including necessary contraindications. Manufacturers must verify that their product labels match the information submitted during the notification process to the MHRA. Compliance with these interpretations is essential for businesses to avoid product seizures or legal action by local Trading Standards officers, ensuring high levels of consumer safety and information transparency.